¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"professional standard review organization"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nominal standard dose
    ¸í¸ñÇ¥Áؼ±·®
  • standard
    1. Ç¥ÁØ, ±âÁØ 2. ±Ô°Ý 3. ¿ø±â
  • standard antibiotic
    Ç¥ÁØÇ×»ýÁ¦
  • standard bicarbonate
    Ç¥ÁØÁßź»ê¿°Ä¡
  • standard condition
    Ç¥ÁØ»óÅÂ
  • standard consistency
    Ç¥Áر»±â, Ç¥Áذ浵
  • standard death rate
    Ç¥ÁØ»ç¸Á·ü
  • standard deviation
    Ç¥ÁØÆíÂ÷
  • standard electrocardiographic lead
    Ç¥ÁؽÉÀüµµÀ¯µµ
  • standard electrode
    ±âÁØÀü±Ø, Ç¥ÁØÀü±Ø
  • standard error
    Ç¥ÁØ¿ÀÂ÷
  • standard limb lead
    Ç¥ÁØÆÈ´Ù¸®Àü±Ø, Ç¥ÁØ»çÁöÀü±Ø
  • standard population
    Ç¥ÁØÀα¸
  • standard serum
    ±âÁØÇ÷û
  • standard sieve
    Ç¥ÁØÃ¼
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • arbitrary standard
    ÀÓÀÇÇ¥ÁØ
  • standard antibiotic
    Ç¥ÁØÇ×»ý¹°Áú
  • standard bicarbonate
    Ç¥ÁØÁßź»ê¿°
  • standard coil
    Ç¥ÁØÄÚÀÏ, Ç¥ÁØÄÚÀϰËÃâ±â
  • standard condition
    Ç¥ÁØ»óÅÂ
  • standard consistency
    Ç¥ÁØÁ¡Á¶µµ
  • nominal standard dose
    ¸í¸ñÇ¥Áؼ±·®
  • standard deviation
    Ç¥ÁØÆíÂ÷
  • effluent standard
    ¹æ·ù±âÁØ
  • environmental standard
    ȯ°æ±âÁØ
  • standard electrode
    ±âÁØÀü±Ø, Ç¥ÁØÀü±Ø
  • standard error
    Ç¥ÁØ¿ÀÂ÷
  • golden standard
    Àý´ëÇ¥ÁØ
  • standard electrocardiographic lead
    Ç¥ÁؽÉÀüµµÀ¯µµ
  • standard limb lead
    Ç¥ÁØ»çÁöÀü±Ø
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • golden standard
    Àý´ëÀûÇ¥ÁØ
  • physical standard
    ½Åü±âÁØ(ãóô÷ÐññÞ).
  • quality standard
    ǰÁúÇ¥ÁØ(̡̰̤̰).
  • reference standard
    Ç¥ÁØÇ°(̡̰̰).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • county health organization
    ±ºº¸°ÇÁ¶Á÷(Ë´ËÓ˧̡̤).
  • county health organization
    ±ºº¸°ÇÁ¶Á÷(ÏÛÜÁËíðÚòÄ).
  • health organization
    º¸°Ç±â±¸
  • local health organization
    Áö¹æº¸°Ç±â±¸(̤ËÑËÓ˧˻˴).
  • organization
    ±â±¸
  • organization
    ±â±¸(˻˴), üÁ¦(̧̡), Á¶Á÷È­(̴̡̤), ±âÁúÈ­(˻̴̤).
  • organization center =organizer
    ±â°üÇü¼º¿ø(Ðïίû¡à÷ê«).
  • pharmaceutical organization
    ¾à»ç°ü°è´Üü(ËâË×Ë´Ë­ËÀ̧).
  • somatotopic organization
    ü¼º¼ø¼­Àû ¹è¿­.
  • topographical organization
    ±¹¼Ò¼ø¼­Àû ¹è¿­
  • topographical organization
    ±¹¼Ò¼ø¼­Àû ¹è¿­.
  • air pollution standard
    ´ë±â¿À¿°±âÁØ (ÊÙ˻̡).
  • arbitrary standard
    ÀÓÀÇÇ¥ÁØ(ËöËô̡̰).
  • community standard
    »ýȰȯ°æ¼öÁØ(Ë×Ì·Ì·Ë­ËàÌ¡), Áö¿ª»çȸ¼öÁØ(ÊÙËàÌ¡).
  • effluent standard
    ¹æ·ù±âÁØ(¡­ÐññÞ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • standard error
    Ç¥ÁØ¿ÀÂ÷(øöñÞè¦ó¬)
  • standard error of estimate
    ÃßÁ¤ Ç¥ÁØ¿ÀÂ÷(õÏïÒøöñÞè¦ó¬)
  • standard error of the mean
    Æò±ÕÄ¡ Ç¥ÁØ¿ÀÂ÷ (øÁгö·øöñÞè¦ó¬)
  • standard flotation coefficient
    Ç¥ÁØ ºÎÀ¯°è¼ö (øöñÞÝ©ë´Ìõâ¦)
  • standard free energy change
    Ç¥ÁØ(øöñÞ) ÀÚÀ¯(í»ë¦)¿¡³ÊÁö º¯È­(ܨûù)
  • standard oxidation potential
    Ç¥ÁØ »êÈ­ÀüÀ§(øöñÞß«ûùï³êÈ)
  • standard potential
    Ç¥ÁØÀüÀ§(øöñÞï³êÈ)
  • standard reaction conditions
    Ç¥ÁØ ¹ÝÀÀÁ¶°Ç(øöñÞÚãëëðÉËì)
  • standard reduction potential
    Ç¥ÁØ È¯¿øÀüÀ§(øöñÞü½êªï³êÈ)
  • standard saline citrate
    Ç¥ÁØ(øöñÞ) ½ÃÆ®¸£»ê(ß«) ½Ä¿°(ãÝç¤)
  • standard sedimentation coefficient
    Ç¥ÁØ Ä§°­°è¼ö(øöñÞöØË½Ìõâ¦)
  • standard solution
    Ç¥ÁØ¿ë¾×(øöñÞéÁäû)
  • standard state
    Ç¥ÁØ »óÅÂ(øöñÞßÒ÷¾)
  • standard temperature
    Ç¥ÁØ ¿Âµµ(øöñÞè®Óø)
  • standard pressure
    Ç¥ÁØ ¾Ð·Â(øöñÞäâÕô)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HCO Health Care Organization; ÀÇ·áÁ¶Á÷
  = MCO; Medical Care Organization
MCO Medical Care Organization; ÀÇ·áÁ¶Á÷
  = HCO; Health Care Organization
MCO managed care organization; medical care organization; multicystic ovary
MSO management service organization; medial superior olive; medical staff organization
EMCRO Experimental Medical Care Review Organization
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HCP health care professional
MHP Mental Health Professional
DUR Drug Use Review
DUR Drug Utilization Review
IRB Institutional Review Board
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • World Health Organization Classification
    ¼¼°èº¸°Ç±â±¸ ºÐ·ù
  • arbitrary standard
    ÀÓÀÇ Ç¥ÁØ
  • ASCII : American National Standard Code for InformationÀÇ ¾àÀÚ.

    ascites

    º¹¼ö, º¹¼öÁõ
    º¹°­³»ÀÇ Àå¾×¼º ¾×üÀÇ »ïÃâ°ú ÃàÀû. abdominal ȤÀº
  • calculus standard index simplified
    ´Ü¼ø Ç¥ÁØ Ä¡¼® Áö¼ö
  • CIE standard illuminant
    ±¹Á¦Á¶¸íÀ§¿øÈ¸ Ç¥ÁØ ±¤¿ø
  • color standard
    »ö Ç¥ÁØ
  • quality standard
    ǰÁú Ç¥ÁØ
  • safe standard
    ¾ÈÀü ±âÁØ
  • safety regulation and standard
    ¾ÈÀü Á¶Àý ¹× Ç¥ÁØ
  • safty standard
    ¾ÈÀü Ç¥ÁØ
  • standard
    Ç¥ÁØ, ±âÁØ
  • standard clasp
    ÁöÁÖ±¸
  • standard consistency
    Ç¥ÁØ Á¡Á¶µµ
  • standard illuminant
    Ç¥ÁØ ±¤¿ø
    »ó´ëÀûÀÎ Èû ºÐ»ê °î¼±ÀÇ ¿ë¾î·Î CIE¿¡ ÀÇÇØ A,B,C,D·Î Á¤ÀǵǴ ±¤¿ø.
  • standard light source
    Ç¥ÁØ ±¤¿ø
    ½ºÆåÆ®·³ ºÐ»ê·ÂÀÌ ¾Ë·ÁÁø ±âÁØ ±¤¿ø.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
review literature Published material which provides an examination of recent or current literature. Reviews can cover a wide range of subject matter of various levels of completeness or comprehensiveness based on analyses of publications on the subject. The review may reflect the state of the art. It also includes reviews as a literary form. The presence of research findings or case reports does not preclude designation as a review.
(12 Dec 1998)
review, multicase A type of review literature giving demographic, laboratory, and clinical data on a group of persons or animals ranging from most of the known cases of a rare condition in large populations on whom the results of research will lead to the establishing of epidemiological analyses or predictions of the occurrence and natural history of diseases. It is differentiated from review of reported cases in that the latter generally reports a single case as a supplement to a presentation, however brief and limited, of other cases known to have been reported.
(12 Dec 1998)
review of reported cases Literature reporting - to the best of the author's ability - all known cases of a disease. The study is usually generated by the investigator's encounter with patients with a given disease and includes the investigator's own cases. The range of time will encompass historical cases and recent cases. The review usually cites the literature in which the known cases were published and may or may not include clinical and laboratory data.
(12 Dec 1998)
review, tutorial A type of review citing literature that will give the user a general and reasonably thorough coverage of a subject with which he may or may not be familiar. It often substitutes as a refresher course for a physician to update his or her awareness or as a crash course for a student unfamiliar with the subject.
(12 Dec 1998)
physician payment review commission A commission created by the consolidated omnibus reconciliation act of 1985, enacted in 1986, and given the mandate to advise congress on medicare-physician payment. The commission members are appointed by the u.s. Office of technology assessment.
(12 Dec 1998)
concurrent review Review of the medical necessity of hospital or other health facility admissions, upon or within a short time following an admission, and periodic review of services provided during the course of treatment.
(12 Dec 1998)
scientific integrity review Designation for reports by the united states office of research integrity, identifying questionable research published in articles or books. Notification of the questionable data is carried in the nih guide for grants and contracts.
(12 Dec 1998)
drug utilization review Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for medicaid programs beginning in 1993.
(12 Dec 1998)
insurance claim review Review of claims by insurance companies to determine liability and amount of payment for various services. The review may also include determination of eligibility of the claimant or beneficiary or of the provider of the benefit; determination that the benefit is covered or not payable under another policy; or determination that the service was necessary and of reasonable cost and quality.
(12 Dec 1998)
utilization review An organised procedure carried out through committees to review admissions, duration of stay, professional services furnished, and to evaluate the medical necessity of those services and promote their most efficient use.
(12 Dec 1998)
allied health professional An individual trained to perform services in the care of patients other than a physician or registered nurse; includes a variety of therapy technicians (e.g., pulmonary), radiology technicians, physical therapists, etc.
(05 Mar 2000)
burnout, professional An excessive stress reaction to one's occupational or professional environment. It is manifested by feelings of emotional and physical exhaustion coupled with a sense of frustration and failure.
(12 Dec 1998)
commission on professional and hospital activities The non-profit, non-governmental organization which collects, processes, and distributes data on hospital use. Two programs of the commission are the professional activity study and the medical audit program.
(12 Dec 1998)
professional autonomy The quality or state of being independent and self-directing, especially in making decisions, enabling professionals to exercise judgment as they see fit during the performance of their jobs.
(12 Dec 1998)
professional competence The capability to perform the duties of one's profession generally, or to perform a particular professional task, with skill of an acceptable quality.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • International Organization of Journalists
    ±¹Á¦ Àú³Î¸®½ºÆ® ±â±¸(IOJ)
  • International Trade Organization
    ±¹Á¦ ¹«¿ª±â±¸(ITO)
  • North Atlantic Treaty Organization
    ºÏ´ë¼­¾ç Á¶¾à ±â±¸(NATO)
  • Warsaw Treaty Organization
    the ¹Ù¸£»þ¹Ù Á¶¾à ±â±¸
  • organization
    Á¶Á÷;±¸¼º;Æí¼º;üÁ¦;´Üü;±â±¸
  • organization man
    Á¶Á÷ÀÎ(ȸ»ç ÀÏ µûÀ§¿¡ ¿­À» ¿Ã¸®´Â »ç¶÷)
  • table of organization
    Æí¼ºÇ¥
  • standard
    Ç¥ÁØ,¸ð¹ü,Ç¥ÁØÀûÀÎ,¸ð¹üÀûÀÎ
  • Central (Standard) Time
    ÁߺΠǥÁؽÃ(G.M.T.º¸´Ù 6½Ã°£ ´ÊÀ½)
  • Eastern Standard time
    µ¿ºÎ Ç¥ÁؽÃ(ij³ª´Ù µ¿ºÎ,¹Ì±¹ µ¿ºÎ,¿À½ºÆ®·¹Àϸ®¾Æ µ¿¹«)
  • International Standard Book Number
    ±¹Á¦ Ç¥ÁØ µµ¼­¹øÈ£(ISBN)
  • International Standard Serial Number
    (¹Ì)±¹Á¦ Ç¥ÁØ °£Ç๰ÀϷùøÈ£
  • Pacific(Standard) Time
    (¹Ì±¹ÀÇ) ÅÂÆò¾ç Ç¥ÁؽÃ
  • Revised Standard Version
    Çö´ë¾î¿ª ¼º°æ(½Å¾àÀº 1946³â,±¸¾àÀº 1952³â¿¡ ¹Ì±¹¿¡¼­ ÃâÆÇ)
  • Standard English
    Ç¥ÁØ¿µ¾î
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á